What does a medical oncologist do?

A medical oncologist treats cancer using chemotherapy or other medications such as targeted therapy or immunotherapy.

What are the typical symptoms of cancer?

There may be Change in bowel or bladder habit, sore that does not heal, Unusual bleeding or discharge, Thickening or lump in the breast or elsewhere, Indigestion or difficulty in swallowing, Obvious change in a wart or mole and hoarseness in voice.

Which tests/ investigations are generally required by the medical oncologist ?

Tests like Biopsy, Bone Marrow Aspiration and Biopsy, Bone Scan, Breast MRI, Colonoscopy, Computed Tomography (CT) Scan, Digital Rectal Exam (DRE) etc are performed.

How long does the chemotherapy session lasts?

Chemotherapy session varies in length and frequency, it depends on the individual treatment plan prescribed by the doctor. Some last as long as three or four hours, while others may only take an half-hour.

What is the difference between a surgical oncologist and a medical oncologist?

A medical oncologist treats cancer using chemotherapy or other medications, such as targeted therapy or immunotherapy wheras the surgical oncologist removes the tumor and nearby tissue during surgery.

Prof. Dr. Ulrich Keilholz, Medical Oncologist in Berlin, Germany - Appointment

About Prof. Dr. Ulrich Keilholz

Prof. Dr. Ulrich Keilholz is a Berlin-based Medical Oncologist with more than 27 years in the field.
He is a Member of the American Society for Clinical Oncology (ASCO), the Deutsche Gesellschaft für Hematology/Oncology (DGHO), Arbeitsgemeinschaft Internistische Oncology (AIO). He was the Vice President (2002-2004) and President (2004-2006) of the International Society for Biological Therapy of Cancer (iSBTc).
He is also on the ESMO Faculty (Principles of Clinical Trials and Systemic Therapy, Melanoma, Tumour Immunology & Immunotherapy), and Annals of Oncology Editorial Board member (2011-2014).
He completed studying medicine at the Universities of Mainz, Heidelberg, Lexington, KY, the USA in 1977, and later pursued a doctoral degree at the Institute of Pathophysiology and Sports Medicine, University of Heidelberg/Germany in 1984.
Prof. Keilholz has a wide experience with investigational therapies and has published in several scientific journals such as Lancet, J Clin Oncology, Blood, Leukemia, Cancer Research, Clinical Cancer Research, etc.
He has been actively involved in nearly 20 clinical phase I, II, and III trials covering diseases in medical oncology and haematology, with focus on sarcoma, melanoma, lymphomas, carcinomas of the stomach, ovary, lung, colon, and kidney.

FAQs About Prof. Dr. Ulrich Keilholz